Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bouwman

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cell Cycle (Georgetown, Tex.)|August 30, 2008
Mouse models for BRCA1 associated tumorigenesis: from fundamental insights to preclinical utilityPeter Bouwman, Jos Jonkers
Molecular and Cellular Endocrinology|October 2, 2002
Regulation of the activity of Sp1-related transcription factorsPeter Bouwman, Sjaak Philipsen
Nature Reviews. Cancer|August 25, 2012
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistancePeter Bouwman, Jos Jonkers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors?Peter Bouwman, Jos Jonkers
Genes & Development|November 7, 2024
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethalityAnna Khalizieva, Sarah C Moser, Peter Bouwman, et al.
The EMBO Journal|January 14, 2015
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeresSophie Badie, Ana Rita Carlos, Cecilia Folio, et al.
Mutagenesis|August 27, 2021
Towards an advanced testing strategy for genotoxicity using image-based 2D and 3D HepG2 DNA damage response fluorescent protein reportersBas Ter Braak, Marije Niemeijer, Liesanne Wolters, et al.
The Journal of Pathology|December 13, 2016
Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in miceMarieke van de Ven, Eline van der Burg, Hanneke van der Gulden, et al.
The Journal of Pathology|March 16, 2011
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppressionPeter Bouwman, Rinske Drost, Christiaan Klijn, et al.
The Journal of Pathology|June 8, 2018
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signalingMarieke van de Ven, Xiaoling Liu, Eline van der Burg, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|August 30, 2008
Mouse models for BRCA1 associated tumorigenesis: from fundamental insights to preclinical utilityPeter Bouwman, Jos Jonkers
Molecular and Cellular Endocrinology|October 2, 2002
Regulation of the activity of Sp1-related transcription factorsPeter Bouwman, Sjaak Philipsen
Nature Reviews. Cancer|August 25, 2012
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistancePeter Bouwman, Jos Jonkers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2013
Molecular pathways: how can BRCA-mutated tumors become resistant to PARP inhibitors?Peter Bouwman, Jos Jonkers
Genes & Development|November 7, 2024
BRCA1 and BRCA2: from cancer susceptibility to synthetic lethalityAnna Khalizieva, Sarah C Moser, Peter Bouwman, et al.
The EMBO Journal|January 14, 2015
BRCA1 and CtIP promote alternative non-homologous end-joining at uncapped telomeresSophie Badie, Ana Rita Carlos, Cecilia Folio, et al.
Mutagenesis|August 27, 2021
Towards an advanced testing strategy for genotoxicity using image-based 2D and 3D HepG2 DNA damage response fluorescent protein reportersBas Ter Braak, Marije Niemeijer, Liesanne Wolters, et al.
The Journal of Pathology|December 13, 2016
Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in miceMarieke van de Ven, Eline van der Burg, Hanneke van der Gulden, et al.
The Journal of Pathology|March 16, 2011
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppressionPeter Bouwman, Rinske Drost, Christiaan Klijn, et al.
The Journal of Pathology|June 8, 2018
BRCA1-associated mammary tumorigenesis is dependent on estrogen rather than progesterone signalingMarieke van de Ven, Xiaoling Liu, Eline van der Burg, et al.
Pageof 5